302 related articles for article (PubMed ID: 36180438)
1. Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.
Lyngse FP; Kirkeby CT; Denwood M; Christiansen LE; Mølbak K; Møller CH; Skov RL; Krause TG; Rasmussen M; Sieber RN; Johannesen TB; Lillebaek T; Fonager J; Fomsgaard A; Møller FT; Stegger M; Overvad M; Spiess K; Mortensen LH
Nat Commun; 2022 Sep; 13(1):5760. PubMed ID: 36180438
[TBL] [Abstract][Full Text] [Related]
2. Household transmission of the SARS-CoV-2 Omicron variant in Denmark.
Lyngse FP; Mortensen LH; Denwood MJ; Christiansen LE; Møller CH; Skov RL; Spiess K; Fomsgaard A; Lassaunière R; Rasmussen M; Stegger M; Nielsen C; Sieber RN; Cohen AS; Møller FT; Overvad M; Mølbak K; Krause TG; Kirkeby CT
Nat Commun; 2022 Sep; 13(1):5573. PubMed ID: 36151099
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China.
Liao Y; Su J; Zhao J; Qin Z; Zhang Z; Gao W; Wan J; Liao Y; Zou X; He X
Front Immunol; 2024; 15():1359380. PubMed ID: 38881892
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
[TBL] [Abstract][Full Text] [Related]
5. Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China.
He X; Liao Y; Liang Y; Yu J; Gao W; Wan J; Liao Y; Su J; Zou X; Tang S
Front Immunol; 2023; 14():1290279. PubMed ID: 38259438
[TBL] [Abstract][Full Text] [Related]
6. How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.
Althaus T; Overton CE; Devaux I; House T; Lapouze A; Troel A; Vanzo B; Laroche M; Bordero A; Jorgensen P; Pebody R; Voiglio EJ
BMC Med; 2024 Jun; 22(1):227. PubMed ID: 38840159
[TBL] [Abstract][Full Text] [Related]
7. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants.
Kim YC; Kim B; Son NH; Heo N; Nam Y; Shin A; Yang AJ; Kim MH; Kyong T; Kang E; Park YS; Kim H
J Korean Med Sci; 2023 Jan; 38(1):e9. PubMed ID: 36593690
[TBL] [Abstract][Full Text] [Related]
9. Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants.
Jalali N; Brustad HK; Frigessi A; MacDonald EA; Meijerink H; Feruglio SL; Nygård KM; Rø G; Madslien EH; de Blasio BF
Nat Commun; 2022 Sep; 13(1):5706. PubMed ID: 36175424
[TBL] [Abstract][Full Text] [Related]
10. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
McCormick DW; Konkle SL; Magleby R; Chakrabarti AK; Cherney B; Lindell K; Namageyo-Funa A; Visser S; Soto RA; Donnelly MAP; Stringer G; Austin B; Beatty ME; Stous S; Albanese BA; Chu VT; Chuey M; Dietrich EA; Drobeniuc J; Folster JM; Killerby ME; Lehman JA; McDonald EC; Ruffin J; Schwartz NG; Sheldon SW; Sleweon S; Thornburg NJ; Hughes LJ; Petway M; Tong S; Whaley MJ; Kirking HL; Tate JE; Hsu CH; Matanock A;
Vaccine; 2022 Aug; 40(33):4845-4855. PubMed ID: 35803846
[TBL] [Abstract][Full Text] [Related]
12. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
[TBL] [Abstract][Full Text] [Related]
14. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
[TBL] [Abstract][Full Text] [Related]
15. Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern.
Lyngse FP; Mølbak K; Denwood M; Christiansen LE; Møller CH; Rasmussen M; Cohen AS; Stegger M; Fonager J; Sieber RN; Ellegaard KM; Nielsen C; Kirkeby CT
Nat Commun; 2022 Jun; 13(1):3764. PubMed ID: 35773247
[TBL] [Abstract][Full Text] [Related]
16. Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination.
Bellusci L; Grubbs G; Zahra FT; Forgacs D; Golding H; Ross TM; Khurana S
Nat Commun; 2022 Aug; 13(1):4617. PubMed ID: 35941152
[TBL] [Abstract][Full Text] [Related]
17. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
Tan ST; Kwan AT; Rodríguez-Barraquer I; Singer BJ; Park HJ; Lewnard JA; Sears D; Lo NC
Nat Med; 2023 Feb; 29(2):358-365. PubMed ID: 36593393
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022.
Baker JM; Nakayama JY; O'Hegarty M; McGowan A; Teran RA; Bart SM; Mosack K; Roberts N; Campos B; Paegle A; McGee J; Herrera R; English K; Barrios C; Davis A; Roloff C; Sosa LE; Brockmeyer J; Page L; Bauer A; Weiner JJ; Khubbar M; Bhattacharyya S; Kirking HL; Tate JE
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):341-346. PubMed ID: 35238860
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection.
Jeong HW; Kim SM; Jung MK; Noh JY; Yoo JS; Kim EH; Kim YI; Yu K; Jang SG; Gil J; Casel MA; Rare R; Choi JH; Kim HS; Kim JH; Um J; Kim C; Kim Y; Chin BS; Jung S; Choi JY; Song KH; Kim YD; Park JS; Song JY; Shin EC; Choi YK
Cell Rep Med; 2022 Oct; 3(10):100764. PubMed ID: 36182684
[TBL] [Abstract][Full Text] [Related]
20. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
Tan ST; Kwan AT; Rodríguez-Barraquer I; Singer BJ; Park HJ; Lewnard JA; Sears D; Lo NC
medRxiv; 2022 Nov; ():. PubMed ID: 36299430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
